Nova Agritech Limited has informed the Exchange regarding Board meeting held on August 09, 2025.
NOVAAGRI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nova Agritech's board, meeting on August 9, 2025, approved its Q1 FY26 (quarter ended June 30, 2025) unaudited standalone and consolidated financial results, along with the Directors' Report for FY25. The company also fixed September 19, 2025 for its 18th AGM via video conferencing and approved the re-appointment of Mr. Kiran Kumar Adapa as Independent Director for a second 5-year term from March 17, 2026. On a standalone basis, revenue from operations fell sharply to about ₹1,165 lakhs from roughly ₹3,314 lakhs in the same quarter last year (around 65% decline). Standalone profit before tax dropped to ₹47 lakhs versus ₹254 lakhs, and standalone PAT came in at about ₹47 lakhs against ₹225 lakhs. On a consolidated basis (including subsidiaries Nova Agri Sciences and Nova Agri Seeds), revenue rose modestly to ₹4,675 lakhs from ₹4,191 lakhs, while consolidated PAT declined to about ₹325 lakhs from ₹428 lakhs. The auditor issued an unmodified limited review report with no qualifications. IPO proceeds of about ₹10,095 lakhs are nearly fully utilised, with only ₹44 lakhs remaining unspent (earmarked for a new formulation plant in the subsidiary).
The steep standalone revenue and profit drop in Q1 FY26 is a red flag and could weigh on near-term sentiment, though the consolidated picture (which captures the subsidiaries' growing contribution) is relatively more stable. Investors should watch whether the standalone weakness reverses in coming quarters and how the new formulation plant ramp-up progresses. The director re-appointment and AGM scheduling are routine governance items with no material impact.